Drug details
Kapvay (clonidine hydrochloride extended-release tablets)
type of
Kapvay (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic agonist used to treat attention deficit hyperactivity disorder (ADHD). Kapvay is available in generic form.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- fainting,
- mood changes,
- irritability,
- severe dizziness
- depression, and
- slow or irregular hearbeat,
The following drugs are related to Kapvay, either as a replacement or used together:
- Adzenys XR-ODT (amphetamine extended-release orally disintegrating tablets)
- Evekeo (amphetamine sulfate tablets, usp)
- Strattera (atomoxetine hcl)
- Azstarys (serdexmethylphenidate and dexmethylphenidate capsules)
- Cotempla XR ODT (methylphenidate extended-release orally disintegrating tablets)
- Daytrana (methylphenidate transdermal)
- Focalin XR (dexmethylphenidate hydrochloride)
- Focalin (dexmethylphenidate hydrochloride)
- Xelstrym (dextroamphetamine)
- Jornay PM (methylphenidate hydrochloride extended-release capsules)
- Vyvanse (lisdexamfetamine dimesylate)
- Metadate CD (methylphenidate hydrochloride extended-release capsules)
- Metadate ER (methylphenidate hydrochloride extended release tablet)
- Ritalin (methylphenidate hcl)
- Ritalin LA (methylphenidate hydrochloride extended-release capsules)
- Quillichew ER (methylphenidate hydrochloride extended-release chewable tablets)
- Qelbree (viloxazine extended-release capsules)